Methscopolamine bromide
- Generic Name
- Methscopolamine bromide
- Brand Names
- Pamine
- Drug Type
- Small Molecule
- Chemical Formula
- C18H24BrNO4
- CAS Number
- 155-41-9
- Unique Ingredient Identifier
- RTN51LK7WL
Overview
A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
Background
A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
Indication
Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.
Associated Conditions
- Peptic Ulcer
Clinical Trials
FDA Approved Products
METHSCOPOLAMINE BROMIDE
Manufacturer:Aarkish Pharmaceuticals NJ Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2024/02/26
NDC:81005-127
METHSCOPOLAMINE BROMIDE
Manufacturer:PD-Rx Pharmaceuticals, Inc.
Route:ORAL
Strength:5 mg in 1 1
Approved: 2023/09/27
NDC:43063-741
METHSCOPOLAMINE BROMIDE
Manufacturer:PD-Rx Pharmaceuticals, Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/09/27
NDC:43063-740
Methscopolamine Bromide
Manufacturer:Breckenridge Pharmaceutical, Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2024/01/10
NDC:51991-191
METHSCOPOLAMINE BROMIDE
Manufacturer:AACE Pharmaceuticals, Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2024/02/05
NDC:71406-126
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath